Reevaluation of a twenty-four-month chronic toxicity/carcinogenicity study of hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) in the B6C3F1 hybrid mouse

International Journal of Toxicology

Volumn 25, Issue 5, 2006, Pages 373-378

  Parker, George A ^a   Reddy, Gunda ^b   Major, Michael A ^b  

^a Biotechnics LLC   (United States)

^b U S ARMY CENTER FOR HEALTH PROMOTION AND PREVENTIVE MEDICINE   (United States)

Author keywords

B6C3F1 mice; Carcinogenicity; Hepatocellular Neoplasm; Hexahydro 1,3,5 trinitro 1,3,5 triazine; RDX

Indexed keywords

CYCLONITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CLASSIFICATION; CARCINOGENICITY; CHRONIC TOXICITY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; INCIDENCE; LIVER ADENOMA; LIVER CARCINOMA; LIVER TUMOR; MALE; MEDICAL ASSESSMENT; MOUSE; NONHUMAN; STATISTICAL ANALYSIS;

ADENOMA; ANIMALS; CARCINOGENICITY TESTS; CARCINOMA; FEMALE; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED STRAINS; TRIAZINES;

EID: 33748672084     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1080/10915810600846245     Document Type: Article

References (16)

1. ATSDR. 1995. Toxicologic Profile for RDX. Agency for Toxic Substances and Disease Registry, Public Health Service, U.S. Department of Health and Human Services.
2. Bock, R. D. 1975. Multivariate statistical methods in behavioral research. McGraw-Hill, New York.
3. Goodman, J. I., D., D. J. Brusick, W. M. Busey, S. M. Cohen, J. C. Lamb, and T. B. Starr. 2000. Reevaluation of the cancer potency factor of toxaphene: Recommendations from a peer review panel. Toxicol. Sci., 55:3-16.
4. Harada, T., A. Enomoto, G. Boorman, and R. Maronpot. 1999. Liver and gallbladder. In Pathology of the Mouse, ed. R. Maronpot, G. Boorman, and B. Gaul, 119-183. Vienna, IL: Cache River Press.
5. Hart, E. R. 1977. Two year feeding study in rats. Litton Bionetics Inc., Kensington, MD. Office of Navel research contract number N00014-73-C-0162. ADAO40161.
6. Levine, B. S., E. M. Furedi-Machacek, V. S. Rac, D. E. Gordon, and P. M. Lish. 1983. Determination of the chronic mammalian toxicological effects of RDX: twenty-four month chronic toxicity/carcinogenicity study of hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) in Fischer 344 rats. Phase V. Vol. 1. Contract No. DAMD 17-79-C-9161. ADA160774. U.S. Army Medical Research and Development Command. Chicago, IL, IIT Research Institute.
7. Lish, P. M., B. S. Levine, E. M. Marianna-Furedi, J. M. Sagartz, and V. S. Rac. 1984. Determination of the chronic mammalian toxicological effects of RDX: Twenty-four month chronic toxicity/carcinogenicity study of hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) in the B6C3F1 hybrid mouse. Final report. Phase VI, Vol. 1. Contract No. DAMD 17-79-C-9161. AD A 160774. U.S. Army Medical Research and Development Command. Chicago, IL, IIT Research Institute.
8. Major, M. A. 1999. Biological degradation of explosives. In Bioremediation of contaminated soil, Monograph no. 37, 111-132. Madison, WI: American Society of Agronomy, Crop Science Society of America, Soil Society of America.
9. Maronpot, R. R., C. A. Montgomery,G.A. Boorman, and E. E. McConnell. 1986. National Toxicology Program nomenclature for hepatoproliferative lesions of rats. Toxicol. Pathol. 14:263-273.
10. Maronpot, R. R., J. K. Haseman, G. A. Boorman, S. E. Eustis, G. N. Rao, and J. E. Huff.1987. Liver lesions in B6C3F1 mice: The National Toxicology Program experience and position. Arch. Toxicol Suppl 10:10-26.
11. McLellan, W. L., W. R. Hartley, and M. E. Brower. 1992. Hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX). In DrinkingWater Health Advisory: Munitions, ed. W. C. Roberts and W. R. Hartley, 133-179. United States Environmental Protection Agency. Office of DrinkingWater Health. Advisories. Boca Raton, FL: Lewis Publishers.
12. Reddy, G., G. I. Erexson, M. A. Cifone, M. A. Major, and G.J. Leach. 2005. Genotoxicity assessment of hexahdro-1,3,5-trinitro-1,3,5-triazine (RDX). Int. J. Toxicol. 24:427-435.
13. Tarone, R. E., K. C. Chu, and J. M.Ward. 1981. Variability in the rates of some common naturally occurring tumors in Fischer 344 rats and (C57BL/6N × C3H/HeN)F1 (B6C3F1) mice. J. Natl. Cancer Inst. 66:1175-1181.
14. USEPA. 2005a. U. S. Environmental Protection Agency. Integrated risk information system (IRIS). www.epa.gov/IRIS/subst/0313.htm. Cincinnati, OH: National Center for Environmental Assessment.
15. USEPA. 2005b. U. S. Environmental Protection Agency. Guidelines for carcinogen risk assessment. EPA630/p-03/001F. Washington DC.
16. Walsh, M. E., and T. F. Jenkins. 1992. Identification of TNT transformation products in soil. Hanover, NH: U. S. Army Corps of Engineers, Cold Regions Research and Engineering Laboratory.